These strategies offer several potential advantages over GLP-1 analogs, including a more natural stimulation of GLP-1 pathways, reduced risk of side effects, and the ability to address metabolic dysregulation at its source However, clinical applicability for pharmacological targets to increase sufficient GLP-1 production and promote L-cell differentiation has not been identified
NASH field celebrates hurrah moment with a first FDA drug approval for the liver disease
The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4
Noom has integrated with Eli Lilly's LillyDirect pharmacy provider Gifthealth to streamline access to FDA-approved Zepbound (tirzepatide) single-dose vials for members with on-label prescriptions, including in-app fill-status and shipping updates
Nothing on the post constitutes or is intended to be a substitute for professional medical advice, prevention, diagnosis, or treatment